Recent developments in cancer care continue to provide promise for patients. Scientists are actively exploring innovative approaches, including immunotherapy , targeted agents, and personalized approaches. A significant study published this week highlights the potential of a experimental drug in treating advanced NSCLC. Furthermore, continued studi